Endocrinology Drugs Market Estimated to Flourish by 2023
This exhaustive research report on the global market for endocrinology drugs offers a thorough assessment, emphasizing specifically on its past and current performance. The growth prospects of this market has also been studied in details in this report to predict its future status.
The rising number of cases of hypogonadism in men, triggered by diabetes and renal or heart disorders, is creating lucrative opportunities for market players. With the increasing intake of medications, the prospects for the market’s growth is likely to be boosted in the years to come. The increasing awareness among people pertaining to thyroid, diabetes, and other hormone-related disorders is also anticipated to drive this market in the future.
Due to the high prevalence of diabetes, the demand for diabetes drugs is higher than other products. Researchers expect this trend to remain so over the next few years, resulting in the high growth rate of the diabetes drug segment. The introduction of novel drug therapies and the presence of robust product pipelines in this market for the treatment of the both types of diabetes mellitus are likely to add significantly to the rise of this segment in the years to come.
Request for Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1598
In terms of the geography, the global endocrinology drugs market boasts of its presence across Asia Pacific, the Middle East and Africa, North America, Europe, and Latin America. Owing to the rising prevalence of endocrine diseases, North America has been dominating the worldwide endocrinology drugs market. Taking the augmenting usage of hormone replacement therapies and the favorable reimbursement policies by the governments in consideration, researchers anticipate the scenario to remain same over the next few years.
Asia Pacific, amongst other, is likely to report a high-paced growth in the years to come on the grounds of the rising prevalence of growth hormone deficiency and the imminent increase in the research and development activities in this region.
The surge in the cases of diabetes and endocrine gland associated cancer, such as end stage renal disorders, is also projected to have a positive impact on the Asia Pacific market for endocrinology drugs in the near future.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1598
The leading producers of endocrinology drugs are Novo Nordisk, Merck, Sanofi, AstraZeneca, Eli Lily, and AbbVie. Some of the other prominent participants in this market are HanAll BioPharma, Bayer HealthCare Pharmaceuticals, Acerus Pharmaceuticals, BHV Pharma, Acrux DDS, Biocon, GSK, Hanmi Pharmaceutical, MannKind, Intrexon, ChipScreen Biosciences, Endo Pharmaceuticals, Takeda Pharmaceuticals, Oramed Pharmaceuticals, MacroGenics, Islet Sciences, KinDex Pharmaceuticals, VeroScience, Transition Therapeutics, and Gan and Lee Pharmaceuticals.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453
TMR Blog: http://www.theglobalhealthnews.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endocrinology Drugs Market Estimated to Flourish by 2023 here
News-ID: 834934 • Views: 207
More Releases from Transparency Market Research
The Role of Urinary Catheters Market Industry Growth, Competitors Analysis, New …
Urinary Catheters Market: Introduction According to the report, the global urinary catheters market was valued at US$ 3.5 Bn in 2020 and is projected to expand at a CAGR of 4.5% from 2021 to 2028. Urinary catheters are used to drain and/or collect urine from the bladder. Urinary catheters are available in different shapes, sizes, materials (latex, silicon, Teflon, etc.) and types (Foley, coude tip, straight, etc.). Urinary catheters have been
Pharmacovigilance Market 2021 : Key Players, SWOT Analysis, Key Indicators, Fore …
Pharmacovigilance Market: Introduction According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before
Digital Health Market 2021 By Emerging Trends, Industry Share, Regional Overview …
Digital Health Market: Introduction According to the report, the global digital health market was valued at US$ 307.7 Bn in 2020 and is projected to expand at a CAGR of 18.3% from 2021 to 2028. The global digital health market is driven by increase in incidence of diabetes, cardiovascular diseases, and other chronic diseases; rise in adoption of digital health products by health care providers, and surge in government initiatives. Digital
The Role of 3D Printing in Medical Applications Market Industry Growth, Competit …
3D Printing in Medical Application Market: Introduction According to the report, the global 3D printing in medical application market was valued at US$ 893.9 Mn in 2020 and is projected to expand at a CAGR of 15.5% from 2021 to 2028. 3D printing has many functions in various industries. It has four key applications in the medical field. The four core uses of 3D printing in the medical field associated with
More Releases for Pharma
Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business